<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F88F6E03-44F0-4016-873E-BA4AD6158CB2"><gtr:id>F88F6E03-44F0-4016-873E-BA4AD6158CB2</gtr:id><gtr:firstName>Belinda</gtr:firstName><gtr:surname>Knight</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BE22AA55-DA2E-4D89-AEF7-56C1607432A1"><gtr:id>BE22AA55-DA2E-4D89-AEF7-56C1607432A1</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Forbes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6D029004-264F-482F-9306-9CD1E6B8AC1B"><gtr:id>6D029004-264F-482F-9306-9CD1E6B8AC1B</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Iredale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1000868"><gtr:id>434A8A47-C219-4460-9E4F-95194B1B39D6</gtr:id><gtr:title>Autologous macrophage therapy promotes stem cell-mediated liver regeneration:a novel therapy for end-stage liver disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000868</gtr:grantReference><gtr:abstractText>Liver disease is the 5th commonest cause of death in the UK and deaths from cirrhosis are rapidly rising. Currently the only curative option for end-stage liver disease is liver transplantation and this is limited in availability due to a lack of suitable donor livers. As a result of this, many patients die whilst waiting for a donor organ, hence new therapeutic strategies for patients with end-stage liver disease are urgently required. Cell therapy using bone marrow has been tested in rodents and has shown to significantly reduce liver scarring, which is a precursor to cirrhosis. We have found that in addition this effect bone marrow therapy stimulates the livers own stem cells to start dividing and regenerate the liver. We have identified the cell type within the bone marrow that is responsible for this effect termed macrophages. This is exciting as these cells can be isolated from a patient?s blood in an immature form in large numbers and matured in the laboratory effectively. 
Here, we describe a novel approach to the treatment of liver cirrhosis using blood derived cells which have been matured outwith the body into macrophages prior to re-injection into the blood stream. This therapy is simple to administer and has the potential to reduce liver scarring and promote liver regeneration. The pre-clinical studies are designed to test the safety and effectiveness of this technique in a wide range of liver disease models- if they are effective they will be directly translated into patients in a clinical pilot study.</gtr:abstractText><gtr:technicalSummary>Liver disease is the 5th commonest cause of death in the UK and deaths from cirrhosis are rapidly rising. Currently the only curative option for end-stage liver disease is liver transplantation and this is limited in availability due to a lack of suitable donor organs. Many patients die whilst waiting for a donor organ, hence new therapeutic strategies for patients with end-stage chronic liver disease are urgently required. 

Autologous bone marrow (BM) cell therapy has been tested in rodent models and has been shown to significantly reduce liver fibrosis. Interestingly, from our studies we have found that in addition to the anti-fibrogenic effect, BM cell therapy also activates the adult liver?s stem cell pool, producing a classic liver progenitor cell (LPC) reaction in the host. This is of considerable interest, as LPCs are known to facilitate liver regeneration in situations in which adult hepatocytes are unable to. Our studies indicate that is the BM-derived macrophages that are the effector cells in this response. Furthermore, we have recently found that na?ve macrophages, matured ex vivo in low adherence culture conditions are as effective as whole BM in eliciting both anti-fibrotic and pro-regenerative effect. Thus macrophage therapy may elicit the dual beneficial effects of reducing fibrosis and regenerating liver from its endogenous stem cell pool. This proposal aims to develop a GMP-compatible system for maturation of monocytes into macrophages using MCSF and low adhesion culture conditions. We will then define the optimal form of LPC-promoting macrophage therapy and rigorously test its safety in a comprehensive series of animal models and explore the mechanism by which macrophage therapy promotes LPC mediated liver regeneration. Using this information we will validate the maturation system for human monocytes and test them in vivo in an immunodeficient mouse (NOG) liver injury model. If pre-clinical studies demonstrate that macrophage therapy is safe and effectively promotes liver regeneration then we will have achieved our milestone to allow us to progress to a clinical study. The clinical study will involve using autologous monocytes, matured ex-vivo into macrophages delivered to suitable patients (as determined by our animal models) with liver cirrhosis. Measured outcomes will include markers of liver function, liver regeneration and liver fibrosis.</gtr:technicalSummary><gtr:fund><gtr:end>2014-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>731226</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research (CIR)</gtr:department><gtr:description>liver fibrosis and regeneration</gtr:description><gtr:id>1D41D3A1-0703-4138-B600-DD088B42E325</gtr:id><gtr:impact>several papers, research training fellowships, a programme grant and a project grant</gtr:impact><gtr:partnerContribution>research collaboration resulting in several publications</gtr:partnerContribution><gtr:piContribution>co-supervision of several joint studentships and clinical training fellowships 
co-PI on a programme grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>liver fibrosis and regeneration</gtr:description><gtr:id>F0DEC63F-6BFC-4304-A8EE-620D8C7D1164</gtr:id><gtr:impact>several papers, research training fellowships, a programme grant and a project grant</gtr:impact><gtr:partnerContribution>research collaboration resulting in several publications</gtr:partnerContribution><gtr:piContribution>co-supervision of several joint studentships and clinical training fellowships 
co-PI on a programme grant</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>outreach meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B969762F-2108-4FA4-B23C-F686E590C5F4</gtr:id><gtr:impact>Public engagement events and lectures via the stem cell network. Attended typically by over 100 members of public to expalin stem cell science and translational potential.

Hosting Nuffield bursary pupils in lab on regular basis</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>271000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>research training fellowship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>0B1B1549-9306-4B05-B5E1-884723DA9FB4</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>239000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC research training fellowship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F4C8D154-7E8C-4BA1-8D22-BA2F7D9D1C15</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>263000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>research training fellowship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>205838F0-EA4B-489B-83E3-B3D0C5CD2FBD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FFEE660-F919-46BC-B1D9-C3ED714C5DD7"><gtr:id>6FFEE660-F919-46BC-B1D9-C3ED714C5DD7</gtr:id><gtr:title>Polysialic acid/neural cell adhesion molecule modulates the formation of ductular reactions in liver injury.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/09377a2fb667394becc775ff6543be43"><gtr:id>09377a2fb667394becc775ff6543be43</gtr:id><gtr:otherNames>Tsuchiya A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3C67D17-77A7-4544-921F-3F7CD6C35150"><gtr:id>C3C67D17-77A7-4544-921F-3F7CD6C35150</gtr:id><gtr:title>Preparing the ground for tissue regeneration: from mechanism to therapy.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0cc27e8940b9a686367e1aaa8e2fec9"><gtr:id>c0cc27e8940b9a686367e1aaa8e2fec9</gtr:id><gtr:otherNames>Forbes SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E41830B-904F-45A8-890C-0BE9B8F1C714"><gtr:id>2E41830B-904F-45A8-890C-0BE9B8F1C714</gtr:id><gtr:title>Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5560243215006bfb22466aeb12c49fd4"><gtr:id>5560243215006bfb22466aeb12c49fd4</gtr:id><gtr:otherNames>Bird TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E26D728-F177-4AE1-9178-454F2B2AA863"><gtr:id>8E26D728-F177-4AE1-9178-454F2B2AA863</gtr:id><gtr:title>Regression of Liver Fibrosis.</gtr:title><gtr:parentPublicationTitle>Seminars in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c43f9538db5bdad65f025ba2fd94131b"><gtr:id>c43f9538db5bdad65f025ba2fd94131b</gtr:id><gtr:otherNames>Campana L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0272-8087</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8FBD3699-E9D5-4ABF-8362-C864CB768446"><gtr:id>8FBD3699-E9D5-4ABF-8362-C864CB768446</gtr:id><gtr:title>WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cada07c08b2731874084f9b42e566470"><gtr:id>cada07c08b2731874084f9b42e566470</gtr:id><gtr:otherNames>Boulter L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8509814A-F0A0-4953-A5C2-AAA3AABAF75A"><gtr:id>8509814A-F0A0-4953-A5C2-AAA3AABAF75A</gtr:id><gtr:title>Hepatic progenitor cells of biliary origin with liver repopulation capacity.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/421e53c0612e3e95281d7e533db9ee5d"><gtr:id>421e53c0612e3e95281d7e533db9ee5d</gtr:id><gtr:otherNames>Lu WY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15F893F6-8A7A-447F-A5FE-E331A46481F1"><gtr:id>15F893F6-8A7A-447F-A5FE-E331A46481F1</gtr:id><gtr:title>Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d3c4db5444be357dea85492f795ee6a"><gtr:id>3d3c4db5444be357dea85492f795ee6a</gtr:id><gtr:otherNames>Pellicoro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9BE8D56-32C3-4392-BE25-2CC5370701B0"><gtr:id>F9BE8D56-32C3-4392-BE25-2CC5370701B0</gtr:id><gtr:title>Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bbb6c2dbdbbbb0453b95e990fc58eae7"><gtr:id>bbb6c2dbdbbbb0453b95e990fc58eae7</gtr:id><gtr:otherNames>Thomas JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/608AAD7F-0A3E-4286-B986-4E8C0FA64F1C"><gtr:id>608AAD7F-0A3E-4286-B986-4E8C0FA64F1C</gtr:id><gtr:title>Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/57cc8704e3792ad9d960f7c56d10fd49"><gtr:id>57cc8704e3792ad9d960f7c56d10fd49</gtr:id><gtr:otherNames>Kallis YN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F08D51D2-0DE0-4DCB-97B3-8F5556CF70C0"><gtr:id>F08D51D2-0DE0-4DCB-97B3-8F5556CF70C0</gtr:id><gtr:title>Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/482af3eb67f4ca194e8027d61bd41d29"><gtr:id>482af3eb67f4ca194e8027d61bd41d29</gtr:id><gtr:otherNames>Gibbons MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2386D122-083D-4438-80F9-D45871441BA4"><gtr:id>2386D122-083D-4438-80F9-D45871441BA4</gtr:id><gtr:title>Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cada07c08b2731874084f9b42e566470"><gtr:id>cada07c08b2731874084f9b42e566470</gtr:id><gtr:otherNames>Boulter L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0821C7E-AD92-43EC-B3AC-AE285AB68BFE"><gtr:id>B0821C7E-AD92-43EC-B3AC-AE285AB68BFE</gtr:id><gtr:title>Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f37697b0f9be7a9abefc1217f1cecb1"><gtr:id>6f37697b0f9be7a9abefc1217f1cecb1</gtr:id><gtr:otherNames>Schrader J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B78C6CDA-1931-4D58-8C09-E5D84E435EA2"><gtr:id>B78C6CDA-1931-4D58-8C09-E5D84E435EA2</gtr:id><gtr:title>Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a836613a298ad0d98ea43821e75d23a4"><gtr:id>a836613a298ad0d98ea43821e75d23a4</gtr:id><gtr:otherNames>Ramachandran P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0866CDBA-827D-4791-844F-AF25A67B68A2"><gtr:id>0866CDBA-827D-4791-844F-AF25A67B68A2</gtr:id><gtr:title>Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2ffb17e3fbef5df65a58e93851bbc036"><gtr:id>2ffb17e3fbef5df65a58e93851bbc036</gtr:id><gtr:otherNames>Williams MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12534AFE-5F13-4EDB-BC43-456346F5B04E"><gtr:id>12534AFE-5F13-4EDB-BC43-456346F5B04E</gtr:id><gtr:title>Differentiation of progenitors in the liver: a matter of local choice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cada07c08b2731874084f9b42e566470"><gtr:id>cada07c08b2731874084f9b42e566470</gtr:id><gtr:otherNames>Boulter L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B19454DD-CF36-4383-B19E-9950A8F6287C"><gtr:id>B19454DD-CF36-4383-B19E-9950A8F6287C</gtr:id><gtr:title>Resolution of liver fibrosis: basic mechanisms and clinical relevance.</gtr:title><gtr:parentPublicationTitle>Seminars in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a836613a298ad0d98ea43821e75d23a4"><gtr:id>a836613a298ad0d98ea43821e75d23a4</gtr:id><gtr:otherNames>Ramachandran P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0272-8087</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07E3BFF0-B1B0-4541-A111-A15E16A35466"><gtr:id>07E3BFF0-B1B0-4541-A111-A15E16A35466</gtr:id><gtr:title>Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell-IL-22 axis.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3577fc614c979ce9faaaf0bb2f68e1e2"><gtr:id>3577fc614c979ce9faaaf0bb2f68e1e2</gtr:id><gtr:otherNames>Duffin R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000868</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>